Antipodes Partners LTD Thermo Fisher Scientific Inc. Transaction History
Antipodes Partners LTD
- $4.06 Billion
- Q3 2025
A detailed history of Antipodes Partners LTD transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Antipodes Partners LTD holds 98 shares of TMO stock, worth $55,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98Holding current value
$55,581% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding TMO
# of Institutions
2,931Shares Held
334MCall Options Held
4.23MPut Options Held
3.56M-
Vanguard Group Inc Valley Forge, PA33.8MShares$19.2 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY29.5MShares$16.7 Billion0.38% of portfolio
-
State Street Corp Boston, MA16.4MShares$9.29 Billion0.28% of portfolio
-
Morgan Stanley New York, NY12.7MShares$7.22 Billion0.39% of portfolio
-
Capital World Investors Los Angeles, CA10.3MShares$5.83 Billion0.71% of portfolio
About THERMO FISHER SCIENTIFIC INC.
- Ticker TMO
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 391,788,992
- Market Cap $222B
- Description
- Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...